Cargando…
Why Drug Safety Should Not Take a Back Seat to Efficacy
The PLoS Medicine editors argue that methodological challenges in monitoring the safety of prescription medications should not mean that drug safety be considered less important than efficacy.
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181229/ https://www.ncbi.nlm.nih.gov/pubmed/21984875 http://dx.doi.org/10.1371/journal.pmed.1001097 |
| _version_ | 1782212736175833088 |
|---|---|
| collection | PubMed |
| description | The PLoS Medicine editors argue that methodological challenges in monitoring the safety of prescription medications should not mean that drug safety be considered less important than efficacy. |
| format | Online Article Text |
| id | pubmed-3181229 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31812292011-10-07 Why Drug Safety Should Not Take a Back Seat to Efficacy PLoS Med Editorial The PLoS Medicine editors argue that methodological challenges in monitoring the safety of prescription medications should not mean that drug safety be considered less important than efficacy. Public Library of Science 2011-09-27 /pmc/articles/PMC3181229/ /pubmed/21984875 http://dx.doi.org/10.1371/journal.pmed.1001097 Text en Editors. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
| spellingShingle | Editorial Why Drug Safety Should Not Take a Back Seat to Efficacy |
| title | Why Drug Safety Should Not Take a Back Seat to Efficacy |
| title_full | Why Drug Safety Should Not Take a Back Seat to Efficacy |
| title_fullStr | Why Drug Safety Should Not Take a Back Seat to Efficacy |
| title_full_unstemmed | Why Drug Safety Should Not Take a Back Seat to Efficacy |
| title_short | Why Drug Safety Should Not Take a Back Seat to Efficacy |
| title_sort | why drug safety should not take a back seat to efficacy |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181229/ https://www.ncbi.nlm.nih.gov/pubmed/21984875 http://dx.doi.org/10.1371/journal.pmed.1001097 |
| work_keys_str_mv | AT whydrugsafetyshouldnottakeabackseattoefficacy |